NA
MEDP icon

NewEdge Advisors’s Medpace MEDP Stock Holding History

NewEdge Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
2,865
+108
+4% +$49.8K ﹤0.01% 1381
2026
Q1 		$1.32M Buy
2,757
+853
+45% +$437K ﹤0.01% 1335
2025
Q4 		$1.07M Buy
1,904
+575
+43% +$326K ﹤0.01% 1447
2025
Q3 		$683K Buy
1,329
+208
+19% +$90.8K ﹤0.01% 1630
2025
Q2 		$352K Buy
1,121
+73
+7% +$21.9K ﹤0.01% 1919
2025
Q1 		$319K Buy
1,048
+190
+22% +$63.9K ﹤0.01% 1859
2024
Q4 		$285K Sell
858
-498
-37% -$169K ﹤0.01% 1906
2024
Q3 		$453K Sell
1,356
-343
-20% -$130K ﹤0.01% 1532
2024
Q2 		$700K Sell
1,699
-376
-18% -$149K 0.01% 1229
2024
Q1 		$839K Sell
2,075
-61
-3% -$21.4K 0.01% 1086
2023
Q4 		$644K Buy
2,136
+557
+35% +$150K 0.01% 1156
2023
Q3 		$382K Sell
1,579
-2,676
-63% -$684K ﹤0.01% 1303
2023
Q2 		$1.02M Buy
4,255
+3,747
+738% +$778K 0.01% 857
2023
Q1 		$95.5K Sell
508
-209
-29% -$43.2K ﹤0.01% 1763
2022
Q4 		$4.4K Sell
717
-4,409
-86% -$881K ﹤0.01% 2636
2022
Q3 		$806K Buy
+5,126
New +$818K 0.01% 738

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

NewEdge Advisors's MEDP Position: Q2 2026 in Review

NewEdge Advisors increased its Medpace (MEDP) stake by 3.9% in Q2 2026, buying an estimated $49.8K and bringing the position to 2,865 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

NewEdge Advisors first reported a position in MEDP in Q3 2022 and has held it in 16 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • NewEdge Advisors held 2,865 shares of Medpace worth $1.52M as of Q2 2026.
  • NewEdge Advisors bought 108 Medpace shares in Q2 2026, an estimated $49.8K.
  • Medpace made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1381 holding.
  • NewEdge Advisors first reported a position in Medpace in Q3 2022 and has held it in 16 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.